Pregled bibliografske jedinice broj: 1103969
Characteristics and Prognosis of Triple- Negative Breast Cancer Patients: a Croatian Single Institution Retrospective Cohort Study
Characteristics and Prognosis of Triple- Negative Breast Cancer Patients: a Croatian Single Institution Retrospective Cohort Study // Acta Clinica Croatica, 59 (2020), 97-108 doi:10.20471/acc.2020.59.01.12 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1103969 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Characteristics and Prognosis of Triple-
Negative Breast Cancer Patients: a Croatian
Single Institution Retrospective Cohort Study
Autori
Tečić Vuger, Ana ; Šeparović, Robert ; Vazdar, Ljubica ; Pavlović, Mirjana ; Lepetić, Petra ; Šitić, Sanda ; Bajić, Žarko ; Šarčević, Božena ; Vrbanec, Damir
Izvornik
Acta Clinica Croatica (0353-9466) 59
(2020);
97-108
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
triple negative breast cancer ; retrospective study
Sažetak
Riple-negative breast cancer (TNBC) occurs in around one-sixth of all breast cancer (BC) patients, with the most aggressive behavior and worst prognosis of all BC subtypes. It is a heterogeneous disease, with specific molecular characteristics and natural dynamics of early recurrence and fast progression. Due to the lack of biomarkers or any valid treatment targets, it can only be treated with classic cytotoxic chemotherapy. We analyzed a cohort of 152 patients, median age 58 years, diagnosed with and treated for early stage TNBC at the University Hospital for Tumors, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia, during the 2009- 2012 period. Patients were treated with primary surgical approach, adjuvant chemotherapy and adjuvant irradiation. We observed a relatively large proportion of locally advanced TNBC at diagnosis, with large tumor size and nodal involvement, with high grade and high proliferation index Ki67. Patient age, tumor size and lymph node involvement, as expected, were significant and clinically most important prognostic factors for 5-year disease-free survival (67% ; 95% CI 60%-75%) and overall absolute survival rate (74% ; 95% CI 66%-81%).
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
Sveučilište Jurja Dobrile u Puli
Profili:
Ljubica Vazdar
(autor)
Sanda Bubanović
(autor)
Robert Šeparović
(autor)
Mirjana Pavlović
(autor)
Damir Vrbanec
(autor)
Ana Tečić Vuger
(autor)
Božena Šarčević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE